Advertisement
Journal Home
Search for

Volume 46, Issue 5, Pages 330-335 (May 2010)


View previous. 7 of 19 View next.

Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma

Raghav C. DwivediaCorresponding Author Informationemail address, Rehan Kazia, Nishant Agrawalb, Edward Chisholma, Suzanne St. Rosec, Behrad Elmiyeha, Catherine Renniea, Christopher Peppera, Peter M. Clarkea, Cyrus J. Kerawalaa, Peter H. Rhys-Evansa, Kevin J. Harringtona, Christopher M. Nuttinga

Received 15 December 2009; received in revised form 18 January 2010; accepted 19 January 2010. published online 02 March 2010.

Summary 

Secondary tumours of small intestine account for 10% of all small bowel cancers. The most common sites of primary tumour metastasizing to small bowel are uterus, cervix, colon, lung, breast and melanoma. The majority of these metastatic tumours come from adenocarcinoma primaries; squamous cell carcinoma constitutes a very small proportion of all metastatic small intestinal lesions. Metastasis to small bowel by head and neck squamous cell carcinoma is extremely rare and carries an unfavourable prognosis. Owing to the limited number of published studies, its characteristic features, clinical presentation and outcomes are poorly described. This work aims at specifying these characteristics by reviewing, compiling, analysing and reporting all published cases in the published literature on small bowel metastasis secondary to head and neck squamous cell carcinoma. To the best of our knowledge, this is the first comprehensive review article on the small intestinal metastasis from head and neck squamous cell carcinoma.

a Head and Neck Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK

b Department of Otolaryngology – Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

c Research, Data and Statistical Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK

Corresponding Author InformationCorresponding author. Tel.: +44 2078082202; fax: +44 2078082235.

PII: S1368-8375(10)00026-6

doi:10.1016/j.oraloncology.2010.01.013


View previous. 7 of 19 View next.

Advertisement